News
Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.
Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.
It is hard to think of a less coherent pair of policies: President Trump’s tax policy encourages the very offshoring that his tariffs are intended to stop.
Javascript is required for you to be able to read premium content. Please enable it in your browser settings. You must be ...
Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and ...
Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 ...
Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns
Eli Lilly's orforglipron reduced A1C and weight in type 2 diabetes, while weekly insulin efsitora matched daily insulin with ...
Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
The market for weight management medicines has been the hottest therapeutic area in the past two years. The pharmaceutical giant has far too much going its way. Analysts predict that the weight ...
Pharmalittle: We’re reading about a Moderna flu vaccine, a J&J loss over 340B rebate plans, and more
Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an ...
Current Position of Eli Lilly Currently trading with a volume of 1,003,032, the LLY's price is down by -3.48%, now at $757.73. RSI readings suggest the stock is currently may be approaching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results